Annals of Epidemiology
Volume 17, Issue 8 , Pages 597-602 , August 2007

Risk of Road Traffic Accidents Associated With the Prescription of Drugs: A Registry-Based Cohort Study

  • Anders Engeland, MSc, PhD, PROF.

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Anders Engeland, Division of Epidemiology, Norwegian Institute of Public Health, P.O.Box 4404 Nydalen, N-0403 Oslo, Norway. Tel.: +47-23-40-82-13; fax: +47-23-40-81-46.
    • ,
  • Svetlana Skurtveit, MSc, PhD, PROF.
    • ,
  • Jørg Mørland, MD, PhD, PROF

Received 11 October 2006 ,Accepted 3 March 2007.

References 

  1. Waller PF. Epidemiology of alcohol-related accidents and the Grand rapid study. Forensic Sci Rev. 2000;12:108–117
  2. Mørland J. Driving under the influence of non-alcohol drugs. Forensic Sci Rev. 2000;12:79–104
  3. Ray WA, Fought RL, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol. 1992;136:873–883
  4. Neutel CI. Risk of traffic accident injury after a prescription for a benzodiazepine. Ann Epidemiol. 1995;5:239–244
  5. Hemmelgarn B, Suissa S, Huang A, Boivin JF, Pinard G. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA. 1997;278:27–31
  6. Neutel CI. Benzodiazepine-related traffic accidents in young and elderly drivers. Human Psychopharmacol. 1998;13:s115–s123
  7. Hammer H. [The central population registry in medical research]. Tidsskr Nor Laegeforen. 2002;122:2550
  8. Statistics Norway. Available at: http://www.ssb.no/english/subjects/10/12/20/vtu_en/. 2006. Accessed May 10, 2007.
  9. Furu K. Drug utilisation in a public health perspective: Establishing a national prescription register in Norway. Nor J Epidemiol. 2001;11:55–60
  10. Furu K, Strøm H, Rønning M, et al. The Norwegian prescription database (NorPD)—A new register for pharmacoepidemiologic research covering a whole nation. Pharmacoepidemiology and Drug Safety. 2005;14(s2):48
  11. WHO Collaborating Centre for Drug statistics and Methodology . Guidelines for ATC Classification and DDD Assignment 2005. Oslo, Norway: WHO Collaborating Centre for Drug Statistics and Methodology; 2005;
  12. WHO Collaborating Centre for Drug Statistics and Methodology . ATC Index with DDDs 2005. Oslo, Norway: WHO Collaborating Centre for Drug Statistics and Methodology; 2005;
  13. Statistics Norway. Available at: http://www.ssb.no/aarbok/tab/tab-424.html. 2007. Accessed May 10, 2007.
  14. Skegg DC, Richards SM, Doll R. Minor tranquillisers and road accidents. Br Med J. 1979;1:917–919
  15. Drummer OH, Gerostamoulos J, Batziris H, Chu M, Caplehorn J, Robertson MD, et al. The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accid Anal Prev. 2004;36:239–248
  16. Kelly E, Darke S, Ross J. A review of drug use and driving: Epidemiology, impairment, risk factors and risk perceptions. Drug Alcohol Rev. 2004;23:319–344
  17. Foley DJ, Wallace RB, Eberhard J. Risk factors for motor vehicle crashes among older drivers in a rural community. J Am Geriatr Soc. 1995;43:776–781
  18. McGwin G, Sims RV, Pulley L, Roseman JM. Relations among chronic medical conditions, medications, and automobile crashes in the elderly: a population-based case-control study. Am J Epidemiol. 2000;152:424–431
  19. Verster JC, Veldhuijzen DS, Volkerts ER. Effects of an opioid (oxycodone/paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size, and mood. Clin J Pain. 2006;22:499–504
  20. Wysenbeek AJ, Klein Z, Nakar S, Mane R. Assessment of cognitive function in elderly patients treated with naproxen. A prospective study. Clin Exp Rheumatol. 1988;6:399–400
  21. Bruce-Jones PNE, Crome P, Kalra L. Indomethacin and cognitive function in healthy elderly volunteers. Br J Clin Pharmacol. 1994;38:45–51
  22. Karplus TM, Saag KG. Nonsteroidal anti-inflammatory drugs and cognitive function: do they have a beneficial or deleterious effect?. Drug Saf. 1998;19:427–433
  23. Goodwin JS, Regan M. Cognitive dysfunction associated with naproxen and ibuprofen in the elderly. Arthritis Rheum. 1982;25:1013–1015
  24. Hoppmann RA, Peden JG, Ober SK. Central nervous system side effects of nonsteroidal anti-inflammatory drugs. Aseptic meningitis, psychosis, and cognitive dysfunction. Arch Intern Med. 1991;151:1309–1313
  25. Hanlon JT, Schmader KE, Landerman LR, Horner RD, Fillenbaum GG, Pieper CF, et al. Relation of prescription nonsteroidal antiinflammatory drug use to cognitive function among community-dwelling elderly. Ann Epidemiol. 1997;7:87–94
  26. Macdonald FC, Gough KJ, Nicoll RA, Dow RJ. Psychomotor effects of ketorolac in comparison with buprenorphine and diclofenac. Br J Clin Pharmacol. 1989;27:453–459

PII: S1047-2797(07)00143-3

doi: 10.1016/j.annepidem.2007.03.009

Annals of Epidemiology
Volume 17, Issue 8 , Pages 597-602 , August 2007

Article Tools